
The Scharenborg Groep is an integrated footcare provider specializing in podiatry and orthopedic services for patients across the Netherlands. The group provides light-touch care to complex footcare solutions through podiatry, orthopedics, and multidisciplinary treatments.
The business adopts a unique approach known as “Total Footcare”, a comprehensive method encompassing foot and movement care, striving to offer the most suitable treatment for all patients. Utilizing cutting-edge technology, supported by scientific research and data-driven practices, Scharenborg Groep significantly influences the quality and cost-effectiveness of footcare, particularly in preventative diabetic treatments. Its approach has effectively reduced ulcer incidence rates well below the national average of 2.2%. This is an achievement which holds significant implications for patients, potentially averting adverse consequences and, in severe cases, preventing the need for amputations.
Gilde Healthcare will support the Scharenborg Groep in its journey to make “Total Footcare” accessible to more patients, as well as continuously improving its offering by investing in people, research, IT, and product development.
More Scharenborg Groep news
NIZO

Performation

Ace Pharmaceuticals
